Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Impact of C-reactive protein on the effect of Roxadustat for the treatment of anemia in chronic kidney disease: a systematic review of randomized controlled trials

Fig. 3

Forest plot of the effect of CRP levels on the efficacy of HIF-PHIs subgroup by dialysis-dependent type. A Random-effect model; B Fixed-effect model. CRP: c-reactive protein; ULN, upper limit of normal; Mean, mean change of Hb from baseline to end of treatment, g/dl; SD, Standard deviation; CI: confidence interval; Total: Total number of patients in the study group; DD-CKD: dialysis-dependent CKD, NDD-CKD: non-dialysis-dependent CKD; df: degrees of freedom; I2, I-squared

Back to article page